A bill that would allow the use of medical cannabis at schools zoomed off the Senate floor Monday afternoon.
Senate Bill 204, co-sponsored by Sens. Candace Gould, R-Albuquerque, and Jacob Candelaria, D-Albuquerque, and Rep. Gail Armstrong, R-Socorro, would allow children who are qualified patients to use the medicine in school settings and permit school personnel to administer it.
With little discussion, 35 senators voted to pass and two did not.
Gould told Senators the bill addresses the problem of students choosing between going to school every day and taking their medicine.
"My constituent came to me, torn between using medicine that's working more effectively for her child's epilepsy with less side effects than the Valium she was using and being able to go to school," she said.
That constituent is Lindsay Sledge, whose daughter Paloma uses cannabis oil regularly to control severe seizures.
Sledge has been pushing to change the law in the state.
Sledge told the Journal she's "very excited" about the Senate's approval of the legislation.
"I'm sort of blown away by the amount of support we've had for the bill," she said. "When I first started doing this whole process, I had several people say this was going to be next to impossible."
Sen. Antoinette Sedillo Lopez, D-Albuquerque, supported the bill during Monday's debate, saying it addresses a problem across the state.
"Since it is the policy of this state to support medical marijuana this is an opportunity to let our schools know that they need to support it for our children as well," she said.
There are currently 175 other children in the state using medical cannabis, Gould said.
Sen. Pat Woods, R-Broadview, who voted not to pass the bill, pushed on SB 204 because it did not appropriate money for storing the medicine.
Gould said the medical cannabis probably would be locked up with other prescription medicines that are allowed on school campuses now.
The bipartisan bill approaches the use of medical cannabis at school much like the use of other drugs at schools.
But districts are allowed to opt out if they can determine they'd lose federal funding because marijuana remains illegal under federal law. SB 204 has a provision that allows parents to appeal to the state Public Education Department if districts are exempted from allowing the medicine at school.
The bill now heads to the House.
"I'm hopeful it will pass its next step quickly," Sledge said.
passed the House Judiciary Committee Saturday and is now headed to the House floor for a vote -- a first in state history.
Meanwhile, Republican senators had their own Cannabis Regulation Act heard in a Senate committee Saturday, too. It also passed."We came to the conclusion that legalization is coming," Sen. Cliff Pirtle, R-Roswell, said. "How can we do it in a way that's more responsible, so we don't have the negative social impacts that Colorado and other states have had?"
"So we wanted to sit down at the table and give our solution, as Republicans, to how we would like to see the regulation of cannabis," he said.
The House bill is sponsored by Democrats and would make it legal for anyone over the age of 21 to possess up to two ounces of pot and grow up to six mature plants in their home. It allows towns and cities to prohibit sales, but not ban the use or growing of plants in private homes.The Senate bill, however, does not allow for homegrown marijuana. It would create a cannabis control commission to regulate cannabis production, sales, and testing, also setting standards on the packaging.
The Republican lawmakers want childproof packaging and labels showing where the pot came from, but these aren't the only concerns when it comes to legalizing weed. Medical marijuana patients want to make sure their cannabis is protected.
"It is not like a batch of cookies where you can go buy ingredients and get more. You have to wait for a whole plant to grow itself before you can get more medicine," said Ginger Grider, a medical cannabis patients advocate. "Even with fines imposed, producers always choose to sell out on the recreational side first because they are going to make money.
"The sponsors of the Senate bill say they agree with her, which is also something Governor Michelle Lujan-Grisham wants. While the House and Senate bills may not be identical, the legalization of recreational marijuana in New Mexico appears to be on the horizon. The specifics of the idea just need to be worked out.If the House bill passes on the floor vote, it heads over to the Senate for consideration. The Senate bill still has to get through a few more Senate committees before it gets a floor vote, then heads over to the House to repeat the process.
Legislation is pending, House Bill 356, to permit the use, possession, and retail sale of cannabis for adults 21 and over.A separate proposal is also pending to permit adult use marijuana sales, Senate Bill 577, with retail stores being regulated and operated by the state government as opposed to being privately operated.
Statewide polling data shows that 60 percent of likely voters support legislation to legalize, regulate and tax marijuana sales to adults 21 and over.
Follow the link to message your lawmakers in support of legalization.
Food and cannabis can be the perfect match. But, let’s be real here: certain kinds of food tend to rule them all—chocolate and hazelnuts being at the top. Nutty, chocolate-packed, and infinitely decadent, adding cannabis to your cocoa hazelnut spread is one of the greatest pairings to be discovered since PB&J. It’s versatile enough to go on just about everything (ice cream, cookies, cake, crackers, you name it), improves even the worst days in mere seconds, and can be eaten straight out of the jar.
Because this delectable spread is so delicious, I highly recommend using a low dose of THC for your oil—you may end up eating the jar much more quickly than anticipated.
4-5 tablespoons milk (plant-based milks are also fine)
1. Preheat oven to 350° Spread hazelnuts on a baking sheet and toast for 10-15 minutes. Let cool.
2. Place a towel over the hazelnuts and roll to create friction, removing the skins. Set aside.
3. Melt chocolate (ideally over a double boiler) until shiny and smooth. Add oil and vanilla then mix to combine.
4. Add hazelnuts to a food processor with salt, cocoa, and powdered sugar. Pulse for 2-3 minutes until the mixture resembles a paste.
5. Slowly drizzle in the chocolate mixture, scraping the sides of the bowl as necessary.
6. Add milk until the mixture is desired consistency. Store in a jar at room temperature for up to two weeks.
*Note: The amount of cannaoil specified in this recipe is a very loose suggestion; the actual amount you use should be modified based on the strength of your butter and the potency you desire. Dosing homemade edibles can be tricky (click here to learn why), so the best way to test for potency is to start with one portion of a serving, wait one to two hours, then make an informed decision on whether to consume more. Always dose carefully and listen to your body, and never drive under the influence of cannabis.
SANTA FE, N.M. (KRQE) - The governor tweeted out Wednesday night saying she's supporting a bill that would expand the commercial and industrial use of hemp.
The bill's sponsor says it's going to bring an economic boom to the state.Lawmakers are looking at different ways to grow New Mexico's economy. The governor and a Democratic representative think hemp is the way to go.
"What this does is provide uniformity in our farmers...ability to send their product to manufacturers to help manufacture hemp products and their byproducts," Rep. Derrick Lente, D-Sandia Pueblo, said.Rep. Derrick Lente says those products and byproducts include things like CBD oils, textiles, cosmetic products, food, and construction materials, just to name a few.
This bill is to make sure New Mexico is in compliance with the federal farm bill, which allows research and industrializes hemp.
Rep. Lente says the hemp bill makes it easier to get a growing license and to be a manufacturer.
"New Mexico is a prime spot to be growing hemp, but it allows, again, our folks in agriculture in rural New Mexico, tribes, everybody to take part in this really growing and booming economy that is now national and worldwide," Sen. Lente said.
Hemp is different from marijuana. Hemp cannot be smoked and you cannot get high from it. Hemp can be made into CBD oils and creams that can help with relieving pain.
Rep. Lente says there are about 2,000 acres of farmland already growing hemp and those farmers hope to produce about $40 million of hemp this year.This isn't the only hemp-related bill this session. Other bills call for more hemp research. If farmers want to grow hemp, they would pay the state about $800 a year to grow it outside and an additional fee for each acre.
The House Financial Services subcommittee on Consumer Protection and Financial Institutions held a hearing Wednesday to address the lack of access to basic banking services by state-legal marijuana businesses.
Currently, state-licensed marijuana businesses face a web of conflicting regulations and federal prohibitions largely prohibit these businesses from partnering with financial institutions, processing credit cards, and taking standard business deductions.
Marijuana could soon become legal in every US state, if a new Senate bill is passed.The bill, playfully labeled S.420, was introduced to the Senate last week by Ron Wyden, a Democrat and Oregon Senator.“It’s time to bring our country’s marijuana policies into the 21st century, and my legislation is the way to do it,” he said in an online statement.“It’s time for Congress to respect the will of the voters in Oregon and nationwide, who are demanding common-sense drug policies.”In practice, the new bill would leave the Drug Enforcement Administration 60 days to remove cannabis from its list of controlled substances, establish a federal tax on all legal sales of the drug, and create federal permits for cannabis businesses.Cannabis products would also have to adhere to advertising standards similar to those required for alcohol.If passed, the bill would become a milestone in US drug history. Because while, for decades, certain states have pursued and approved cannabis legalization, the plant remains illegal at the US federal level – a clause that has criminalized most actions involving the drug, including scientific research.Three bills outside Washington DCAlong with S.420, Wyden introduced two other pieces of cannabis legislation.The bill S.421 would “reduce the gap between federal and state marijuana policy.” A broad, progressive proposal, if passed, the bill would allow banks access to cannabis companies, expunge criminal records, shield immigrants from deportation, and allow the Department of Veterans Affairs to issue medical cannabis to patients.The third bill, S.422, is the only piece of legislation that comes with initial cosponsors. Along with Wyden, Senators Rand Paul (R-KY), Michael Bennet (D-CO) and Patty Murray (D-WA) have also endorsed the bill, which seeks to remove state-legal cannabis businesses from the federal provision, a restriction that prevents companies from taking business tax deductions.Will they pass?While Wyden’s bills may seem historic, they are far from the first attempts to remove cannabis from federal prohibition. They aren’t even Wyden’s first attempt.During the last Congress, the Oregon senator filed three nearly identical bills. None were brought to vote.And only last month, Representative Earl Blumenauer (D-OR) proposed another bill monikered 420, that would move regulations to treat cannabis like alcohol.“While the bill number may be a bit tongue-in-cheek, the issue is very serious,” says Blumenauer in an online statement. “Our federal marijuana laws are outdated, out of touch and have negatively impacted countless lives.”But advocates are hopeful about the latest trio of bills. Backed by rising support of reform legalization and the economic viability of the cannabis industry, many feel that 2019 is the right time to take this progressive step.“Too many lives have been wasted and too many economic opportunities have been missed,” reads Wyden’s online statement.“It’s time for Congress to respect the will of the voters in Oregon and nationwide, who are demanding common-sense drug policies.”Representative Blumenauer’s bill be discussed at a US House Committee hearing on February 13th.A hearing to discuss Senator Wyden’s bills has yet to be booked.https://www.analyticalcannabis.com/articles/senator-introduces-420-bill-to-legalize-cannabis-federally-311482?fbclid=IwAR0nR0TMPMNkNFCOamJkG_l0Rd3fHz3WgdevF9Q6OhGXochgwt2qfPI3tjw
Island Sweet Skunk, sometimes called Sweet Island Skunk, is a sativa strain that users enjoy for its energetic effects. The flavor is most easily described as “sweet skunk,” where tropical fruit flavors take the lead. Often the fruity aroma is likened to grapefruit.
Users describe the Purple Haze high as one with almost immediate high-energy cerebral stimulation accompanied by an intense sense of creative inspiration and blissful contentment. You may experience a mild body buzz that is warming and spreads from your head and neck throughout the rest of your body. Due to these potent effects, Purple Haze in ideal strain for treating patients suffering from conditions such as fatigue, mild to moderate cases of depression, and chronic stress or anxiety.
Purple Haze has a sweet earthy berry aroma and a pungent berry taste with a hint of spice.
King Tut the strain is a sativa-dominant hybrid (sativa/indica ratio of 80:20) with an uncertain parentage, though it’s known to descend from the legendary sativa-dominant AK-47. The high is cerebral and peppy, making this a good choice for daytime errands, social events, or creative endeavors. Use this strain to treat depression, chronic pain, stress, inflammation, and nausea. King Tut tastes like fresh fruit and flowers and has a sour, Skunky smell.
Recreational marijuana is one step closer to becoming a reality in our state.
On Saturday, HB 356 advanced in the House Health and Human Services Committee. HB 356 would regulate the use, production and sale of cannabis and cannabis products for those over the age of 21.
"It's time that we end the prohibition of cannabis," said Rep. Javier Martinez, one of the sponsors of the bill.
"This proposed legislation ensures that we lead the way with a legalization framework that protects medical cannabis patients, ensures public safety, and advances social justice for low-income, communities of color."
The bill includes public health and safety provisions, as well as investments in safety and education.
It would potentially create a Community Reinvestment Fund that would be used to fund numerous resources like legal services, medical care, outreach services and education for youth.
The bill now moves to the House Judiciary Committee.
Senator Ron Wyden has introduced legislation in the Senate — The Marijuana Revenue and Regulation Act— to permit states to establish their own marijuana regulatory policies free from federal interference. In addition to removing marijuana from the United States Controlled Substances Act, this legislation also removes enforcement power from the US Drug Enforcement Administration in matters concerning marijuana possession, production, and sales — thus permitting state governments to regulate these activities as they see fit.Click here to send a message to your lawmakers in support of Senate Bill 420 now!“Senate Bill 420 is another sign that the growing public support for ending our failed war on cannabis consumers nationwide is continuing to translate into political support amongst federal officials,” said NORML Political Director Justin Strekal. “If we are truly going to move our nation towards sensible marijuana policies, the removal of marijuana from the Controlled Substances Act is paramount. Annually, 650,000 Americans are arrested for nothing more than the possession of small amounts of marijuana and now is the time for Congress to once and for all end put an end to the national embarrassment that is cannabis prohibition. With marijuana legalization being supported by a supermajority of Americans while Congress’ approval rating hovers around 20 percent, ending our country’s disastrous prohibition against marijuana would not just be good policy, but good politics.”Upon introduction, Senator Wyden said,“The federal prohibition of marijuana is wrong, plain and simple. Too many lives have been wasted, and too many economic opportunities have been missed. It’s time Congress make the changes Oregonians and Americans across the country are demanding.”Representative Earl Blumenauer, who will carry the House companion legislation, said, “Oregon has been and continues to be a leader in commonsense marijuana policies and the federal government must catch up,” said Blumenauer. “The American people have elected the most pro-cannabis Congress in American history and significant pieces of legislation are being introduced. The House is doing its work and with the help of Senator Wyden’s leadership in the Senate, we will break through.”Legislative text for the Marijuana Revenue and Regulation Act can be found here.Thirty-three states, Washington, D.C. and the U.S. territories of Guam and Puerto Rico have enacted legislation specific to the physician-authorized use of cannabis. Moreover, an estimated 73 million Americans now reside in the ten states where anyone over the age of 21 may possess cannabis legally. An additional fifteen states have passed laws specific to the possession of cannabidiol (CBD) oil for therapeutic purposes.Sixty-eight percent of registered voters “support the legalization of marijuana,” according to national polling data compiled by the Center for American Progress. The percentage is the highest level of support for legalization ever reported in a nationwide, scientific poll.Majorities of Democrats (77 percent), Independents (62 percent), and Republicans (57 percent) back legalization. The results of a 2017 nationwide Gallup poll similarly found majority support among all three groups.To date, these statewide regulatory programs are operating largely as voters and politicians intended. The enactment of these policies have not negatively impacted workplace safety, crime rates, traffic safety, oryouth use patterns. Instead, they have stimulated economic development and created hundreds of millions of dollars in new tax revenue.Specifically, a 2017 report estimates that over 149,000 Americans are now working full-time in the cannabis industry. Tax revenues from states like Colorado, Oregon, and Washington now exceed initial projections. Further, numerous studies have identified an association between cannabis access and lower rates of opioid use, abuse, hospitalizations, and mortality.https://blog.norml.org/2019/02/08/s-420-introduced-to-end-federal-prohibition-and-regulate-marijuana-nationwide/
Pain is the number one reason people seek medical care—and quite possibly medical cannabis—and it affects more people than diabetes, heart disease, and cancer combined. In the clinic, pain is often treated with opioid drugs like OxyContin, Percocet, Vicodin, and Fentanyl. This has traditionally been a first-line treatment approach because they work—at first.
On their own, low doses of cannabis or opioids do not relieve pain, but in combination, they do.
But opioid use has spiraled out of control and we find ourselves amidst an opioid epidemic that cost the U.S. $504 billion in 2015 alone, claims the lives of over 30,000 annually, and damages the quality of life of countless others. Clearly, we must do something to curb the growing opioid epidemic, but unfortunately, it appears that the federal government is ignoring one of its strongest solutions: cannabis.
We know that cannabis is effective in treating chronic pain. We understand its ability to effectivelysubstitute for opioid medication, and that CBD can combat opioid abuse by reducing its rewarding effects. Here, we’ll take a look at how cannabis enhances the effects of opioids—an interaction worth exploring in an era plagued by opioid dependence and overdose.
CB1 Receptors Are Important for the Effects of Opioids
The original natural painkiller, opium, dates back to 3,400 B.C. in Southwestern Asia. Cannabis followed a half a century later. It’s unclear if they were ever used together to treat pain, but consumers would have found profound pain relief from low doses of both drugs when used together.Science is revealing that the cannabinoid and opioid systems can work synergistically to achieve greater pain relief. This interaction becomes clear when you consume super low-doses of THC or opioids; on their own, these low doses do not relieve pain, but in combination, they do.
For instance, a recent double-blinded, placebo-controlled study (the gold-standard in clinical research) investigated the effects of low-dose cannabis (5.6% THC) and the opioid drug, oxycodone (2.5 mg) on pain thresholds in human subjects. Neither THC nor oxycodone independently affected pain, but when used in combination, participants were able to withstand higher levels of painful stimuli consistent with substantial pain reductions.To achieve these pain-relieving effects, could THC’s primary target, cannabinoid type I (CB1) receptors, and opioid receptors be working together? There’s evidence that they do.Take mice that have been genetically engineered to not express CB1 receptors (that’s right, you can create mice without CB1 receptors!). These mice enjoy nicotine, amphetamines, cocaine, and they’ll eagerly press a lever to self-administer these drugs. But they won’t do it for the opioid drug, heroin. Normal mice do, but not the mice without CB1 receptors. This tells us that CB1 receptors are important in the euphoric effects of heroin. Extending these findings to pain, blocking the activity of CB1 receptors weakensmorphine’s ability to reduce pain.
So CB1 receptors are important in opioid drugs’ ability to make you feel good and reduce pain.These are two critical elements driving the opioid epidemic and an integral component of the pain experience. After all, pain is subjective. The severity of pain is determined by numerous factors including:
Incoming signals from an injured area (e.g., knee inflammation)
Cognitive factors (e.g., attention to injury)
Contextual factors (e.g., do you expect it to be painful?)
Mood factors (e.g., are you already depressed or anxious?)
Chemical factors (e.g., endocannabinoid or opioid system function)
Genetics (e.g., are you predisposed to have low opioid levels?).
Opioid medications predominately target two of these factors. First, they weaken the strength of the pain signals from the site of injury to your brain, and second, they improve your mood by boosting levels of the pleasurable dopamine chemical.
These dual effects make stopping opioid use difficult, especially when repeated opioid use leads to long-term brain changes that reduce the number of opioid receptors in the brain and body. Lower numbers of opioid receptors enable stronger pain signals to enter your brain and reduces the levels of mood-boosting dopamine. This is the phenomenon of tolerance, which leads to increased opioid consumption, the transition to stronger drugs, and increased risk for overdose and death.
CB1 and Opioid Receptors Interact
Pain signals begin at the site of injury, then make their way into the spinal cord and travel up to the brain. After exiting the spinal cord, they activate brain cells in critical pain processing regions including the periaqueductal gray, thalamus, and cortex. If you were to design a pain medication, you’d try to (a) weaken pain signals as they enter and exit the spinal cord and (b) dampen their effect in the brain.CB1 receptors and opioid receptors, specifically the µ-opioid receptors that modulate pain, are found expressed together in the spinal cord, the periaqueductal gray, and the brain’s reward centers. That is, you find these two receptors together in all the places that are important in pain relief.
Once activated by either opioids or cannabinoids, they share many common downstream signaling features. In fact, if you activate one receptor, it affects how the other one responds. This has led many to believe that the CB1 and µ-opioid receptors physicallyinteract. The consequence of this interaction depends on where in the brain they’re found, but in some cases, it means that their co-activation by low amounts of drug leads to a stronger effect than what would be predicted by activating either CB1 or opioid receptors on their own.While the physical interaction between CB1 and opioid receptors is likely important for the pain-relieving effects of cannabis and opioids, cannabis can enhance the effect of opioids by also increasing the body’s endogenous opioid levels, themselves. The effect is reciprocal; THC can increase opioid levels to help relieve pain, and using drugs to boost the body’s own opioid levels enhances THC’s pain-relieving effects.
So, taken together, cannabis can increase opioid’s pain-relieving effects by modulating opioid-receptor signaling directly through physical interaction between CB1 and opioid receptors, and by increasing the body’s own opioid levels.
SANTA FE, N.M. (KRQE) - For the first time this session, lawmakers are taking a stab at legalizing recreational marijuana in the state.The bill, sponsored by House Democrats, would make it legal for anyone 21 and over to possess up to two ounces of pot.It also provides for a person to grow up to six mature plants in their home.
The law would allow towns and cities to ban the sale of pot, but they could not ban the use or growing of marijuana in private homes.The bill will have to clear two House communities to be heard on the House floor.
Chronic pain can be an incredibly debilitating condition. For many who live with it on a daily or near daily basis, the condition can be so oppressive, it affects other parts of their lives, impacting their mood, health, and overall well-being. Unfortunately, many treatment options are only nominally effective. Worse, commonly prescribed drugs like opioids are highly addictive and potentially toxic; 28,000 people died from an opioid overdose in 2014, more than any other year in history. No wonder a growing number of the estimated one in five Americans who suffer from chronic pain are turning to cannabis as an alternative.
While many people believe cannabis to be an effective treatment, what does the science say? Is it really more effective and safer than other drugs? Fortunately, when it comes to cannabis and cannabinoid-based formulations, chronic pain is one of the best studied conditions. However, the causes of chronic pain are diverse. Moreover, chronic pain can be nociceptive or neuropathic. Nociceptive pain is caused by tissue damage or inflammation. Neuropathic pain is caused by nervous system damage or malfunction.
Everyone’s biology is unique and will respond differently to cannabis depending on a number of variables, including what type of chronic pain they experience, dosage, strain, and administration method (vaping, edibles, tinctures, etc.).
How Effective is Cannabis for Chronic Pain Relief?
In a comprehensive, Harvard-led systematic review of 28 studies examining the efficacy of exo-cannabinoids (e.g. synthetic formulations or cannabinoids from the plant) to treat various pain and medical issues, the author concluded, “Use of marijuana for chronic pain, neuropathic pain, and spasticity due to multiple sclerosis is supported by high quality evidence.”Of the studies reviewed, six out of six general chronic pain studies and five out of five neuropathic pain studies found a significant improvement in symptoms among patients. Notably, while most of the studies were limited to synthetic preparations of cannabinoids, three of the five neuropathic pain studies investigated “smoked” cannabis, while two examined an oral spray preparation.
Dr. Donald Abrams, a professor and Chief of Hematology/Oncology at San Francisco General Hospital, supports cannabis to treat chronic pain, suggesting the following:
“Given the safety profile of cannabis compared to opioids, cannabis appears to be far safer. However, if a patient is already using opioids, I would urge them not to make any drastic changes to their treatment protocol without close supervision by their physician.”
Both THC and CBD in cannabis are known to elicit analgesic effects, especially when used together due to their congruent chemical synergies.
Cannabis vs. Opioids
North America has been hit hard by the opioid epidemic. Prescriptions have increased 400% percent since 1999, and with this trend a shocking increase in fatal overdoses has followed. Every day, 40 people now die from prescription narcotic overdoses. Many also move on to heroin because it is cheaper, easier to find, and more potent.Could cannabis be part of the solution? Quite possibly. An increasing number of studies provide evidence that many patients can use cannabis instead of opioids to treat their pain, or they can significantly reduce their reliance on opioids.
A University of Michigan March 2016 study published in the Journal of Pain provides some compelling data. They found that cannabis:
Decreased side effects from other medications
Improved quality of life
Reduced use of opioids (on average) by 64%
“We are learning that the higher the dose of opioids people are taking, the higher the risk of death from overdose,” said Dr. Daniel Clauw, one of the study’s researchers and a professor of pain management anesthesiology at the University of Michigan Medical School. “[The] magnitude of reduction in our study is significant enough to affect an individual’s risk of accidental death from overdose.”Kevin Ameling, a chronic pain patient who now works for a Colorado-based non-profit cannabis research advocacy group called the IMPACT Network, is a success story. Ameling believes cannabis saved him from a life of dependency on prescription drugs. In 2007, he suffered a severe fall and was prescribed a cocktail of prescription drugs that included OxyContin, Tramadol, Clonazepam, and Lexapro. The pain became so severe that he had to progressively increase dosage while the OxyContin became less and less effective.
Living in Colorado, he decided to try medical marijuana in 2013. He claims he achieved results immediately and was able to significantly reduce his prescription intake. He cut his OxyContin dosage by 50%, reduced Clonazepam from 3 mg to 0.5 mg, Lexapro from 30 mg to 5 mg, and Tramadol from 300 mg to 75 mg.“It’s hard to express in words what a life changer medical marijuana has been for me,” said Ameling. “I was becoming increasingly worried about having to take higher doses of prescription drugs that can be highly addictive and toxic. Not only was I able to cut back significantly, with cannabis I can often skip the OxyContin with no adverse effects, something I couldn’t do before.”
Cannabis Can Take a Bit of Trial and Error
Ameling added, “Everyone will respond differently. For me, I found smoking can worsen my symptoms, while low dose edibles work the best.”No doubt, the chemical composition of the strain you choose and how you consume will affect the outcome. It may take a little trial and error before you find the most effective cannabis strain, dose, and preferred method of administration for your pain. Most importantly, if you are currently using opioids, exercise extreme caution. A change in treatment protocol should be done under medical supervision.
And, finally, heed the advice of Dr. Michael Hart, head physician at Marijuana for Trauma in Canada: “When considering cannabis to treat chronic pain, the adage ‘less is more’ rings true. Patients seem to find more relief in indica strains which are higher in THC than most sativa or hybridstrains. What we’ve found is that these strains can be highly effective in low to moderate doses, but could actually make pain worse in higher doses. So it’s important to start low, and titrate up as appropriate.”https://www.leafly.com/news/health/cannabis-for-chronic-pain-vs-opioids